Skip to main content
Clinical Trials/ISRCTN98312560
ISRCTN98312560
Active, not recruiting
未知

Efficacy and mechanism of electroacupuncture in the treatment of ischemic stroke: a prospective randomized controlled trial

Science, Technology and Innovation Commission of Shenzhen Municipality0 sites60 target enrollmentApril 15, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Science, Technology and Innovation Commission of Shenzhen Municipality
Enrollment
60
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 15, 2023
End Date
October 31, 2025
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Science, Technology and Innovation Commission of Shenzhen Municipality

Eligibility Criteria

Inclusion Criteria

  • 1\. A diagnosis of ischemic stroke according to the American Heart Association/American Stroke Association
  • 2\. Participants with acute and subacute stroke, the stroke onset within 2 weeks
  • 3\. Aged 18 to 80 years old
  • 4\. After treatment, symptoms were stable
  • 5\. Patients are conscious and are able to finish all examinations and evaluations
  • 6\. Patients sign a written informed consent and voluntarily participate in this study

Exclusion Criteria

  • 1\. Patients with severe heart, lung, liver, and kidney dysfunction
  • 2\. Patients with diseases which affect cognitive function assessment, including neurodegenerative diseases, mental illnesses, and others
  • 3\. Patients with diseases which affect motor function assessment, including epilepsy, movement disorders, and others
  • 4\. Patients with aphasia, severe visual and auditory disorders
  • 5\. Patients with brain tumor and craniocerebral injury
  • 6\. Long\-term using sedatives and antidepressants
  • 7\. Patients cannot receive electroacupuncture treatment, due to needle fainting, and cannot cooperate with the researcher for other reasons

Outcomes

Primary Outcomes

Not specified

Similar Trials